عرض بسيط للتسجيلة

المؤلفEjaj, Ahmad
المؤلفAli, Asgar
المؤلفFatima, Munazza Tamkeen
المؤلفNimisha
المؤلفApurva
المؤلفKumar, Arun
المؤلفSumi, Mamta P.
المؤلفSattar, Real Sumayya Abdul
المؤلفMahajan, Bhawna
المؤلفSaluja, Sundeep Singh
تاريخ الإتاحة2023-09-05T08:39:25Z
تاريخ النشر2021-05-31
اسم المنشورPharmacological Research
المعرّفhttp://dx.doi.org/10.1016/j.phrs.2021.105544
الاقتباسAhmad, E., Ali, A., Fatima, M. T., Kumar, A., Sumi, M. P., Sattar, R. S. A., ... & Saluja, S. S. (2021). Ligand decorated biodegradable nanomedicine in the treatment of cancer. Pharmacological Research, 167, 105544.‏
الرقم المعياري الدولي للكتاب10436618
معرّف المصادر الموحدhttps://www.sciencedirect.com/science/article/pii/S1043661821001286
معرّف المصادر الموحدhttp://hdl.handle.net/10576/47237
الملخصCancer is one of the major global health problems, responsible for the second-highest number of deaths. The genetic and epigenetic changes in the oncogenes or tumor suppressor genes alter the regulatory pathways leading to its onset and progression. Conventional methods are used in appropriate combinations for the treatment. Surgery effectively treats localized tumors; however, it fails to treat metastatic tumors, leading to a spread in other organs, causing a high recurrence rate and death. Among the different strategies, the nanocarriers-based approach is highly sought for, but its nonspecific delivery can cause a profound side effect on healthy cells. Targeted nanomedicine has the advantage of targeting cancer cells specifically by interacting with the receptors overexpressed on their surface, overcoming its non-specificity to target healthy cells. Nanocarriers prepared from biodegradable and biocompatible materials are decorated with different ligands by encapsulating therapeutic or diagnostic agents or both to target cancer cells overexpressing the receptors. Scientists are now utilizing a theranostic approach to simultaneously evaluate nanocarrier bio-distribution and its effect on the treatment regime. Herein, we have summarized the recent 5-year efforts in the development of the ligands decorated biodegradable nanocarriers, as a targeted nanomedicine approach, which has been highly promising in the treatment of cancer.
اللغةen
الناشرElsevier
الموضوعHyaluronic Acid
Biodegradable nanocarriers
Transferrin
Phospholipids
CD44
العنوانLigand decorated biodegradable nanomedicine in the treatment of cancer
النوعArticle
رقم المجلد167
dc.accessType Abstract Only


الملفات في هذه التسجيلة

الملفاتالحجمالصيغةالعرض

لا توجد ملفات لها صلة بهذه التسجيلة.

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة